count down to strategic review, page-4

Ecsc,
CR is expected as most of the US based bio companies refer to hold at least 3 years of operational cash reserve. I would think management will try to raise additional $50mil USD at least this year.

Lets just hope that they do some meaningful marketing efforts to intos before having any placement at a little premium for a change..